11/7/2024
07:00 am
mltx
Q3/2024 9/30/2024 EPS -0.560 ZacksConsensus -0.440 ActVsEst (0.120) - Miss
Low
Report
moonlake immunotherapeutics - class a ordinary shares
8/7/2024
08:00 am
mltx
Q2/2024 6/30/2024 EPS -0.390 ZacksConsensus -0.280 ActVsEst (0.110) - Miss
Low
Report
moonlake immunotherapeutics - class a ordinary shares
5/7/2024
08:00 am
mltx
Q1/2024 3/31/2024 EPS -0.220 ZacksConsensus -0.210 ActVsEst (0.010) - Miss
Medium
Report
moonlake immunotherapeutics - class a ordinary shares